Ionis Pharmaceuticals, Inc (NASDAQ:IONS) Sees Large Increase in Short Interest theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Ionis Pharmaceuticals (NASDAQ:IONS – Free Report) had its price objective raised by Oppenheimer from $65.00 to $72.00 in a report issued on Wednesday, Benzinga reports. The firm currently has an outperform rating on the stock. Several other research analysts have also recently weighed in on IONS. Bank of America raised Ionis Pharmaceuticals from a neutral […]
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) shares traded down 4.5% during mid-day trading on Thursday . The stock traded as low as $46.84 and last traded at $46.85. 1,400,503 shares were traded during trading, an increase of 23% from the average session volume of 1,139,582 shares. The stock had previously closed at $49.07. […]
Ionis Pharmaceuticals, Inc (NASDAQ:IONS) Given Consensus Recommendation of Moderate Buy by Brokerages theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) have received a consensus rating of “Moderate Buy” from the fourteen research firms that are currently covering the stock, Marketbeat reports. Two analysts have rated the stock with a sell rating, four have given a hold rating, seven have given a buy rating and one […]